Last updated on November 2019

A Randomized, Double-blind, Placebo-controlled, Dose Ranging, Parallel-group Study of the Efficacy and Safety of Plecanatide in Children 6 to less than 18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C)

Brief description of study

To evaluate the safety and efficacy of once daily oral plecanatide for 4 weeks as treatment for the relief of symptoms associated with IBS-C in children ages 6 to < 18 years.


Clinical Study Identifier: TX229385

Find a site near you

Start Over

Northwest Clinical Research Center

1951 152nd Pl NE Suite 200 Bellevue, WA United States
  Connect »